News

Genmab to Host Virtual 2024 R&D Update and ASH Review

Genmab to Host Virtual 2024 R&D Update and ASH Review

Genmab to Host 2024 R&D Update Meeting

Global biotechnology company Genmab A/S (NASDAQ: GMAB) is set to conduct its 2024 R&D Update and ASH Data Review Meeting. This significant event will be held virtually, allowing participants to join from anywhere and gain valuable insights regarding the company’s innovative research and drug development initiatives.

Event Details and Accessibility

The meeting is scheduled to take place virtually, featuring a live webcast to accommodate a global audience. Attendees will not only have the opportunity to hear directly from Genmab’s leadership but also engage with the content post-event as there will be an archiving of the session on Genmab’s website. This broad accessibility demonstrates Genmab's commitment to transparency and engagement with its stakeholders.

Genmab's Commitment to Innovation

At the heart of Genmab's mission is the development of innovative therapies designed to enhance the lives of patients suffering from cancer and other serious diseases. Their approach leverages unique technology platforms that focus on creating antibody-based therapeutics. Over the years, Genmab has made strides in the field, setting a high bar with bispecific T-cell engagers, antibody-drug conjugates, and advanced immune checkpoint modulators.

Vision for the Future

Genmab has a commendable goal set for 2030: to significantly transform the patient experience in oncology through what they term 'knock-your-socks-off' (KYSO®) antibody medicines. This vision reflects their unwavering commitment to research excellence and patient-centric therapy innovation.

Upcoming Presentations and Data Review

In addition to the research updates presented during the meeting, Genmab plans to showcase findings from recent studies at the American Society of Hematology (ASH) meeting. These presentations are crucial for communicating the progress and efficacy of their product pipeline, underscoring Genmab's dedication to advancing medical science and patient care.

Global Operations and Impact

Founded in 1999, Genmab has expanded its international presence significantly, operating across North America, Europe, and the Asia-Pacific region. This global reach enhances their ability to collaborate with various partners, driving innovation and expanding access to their groundbreaking therapies.

Contact Information for Further Inquiries

For those interested in additional insights or wishing to engage further with Genmab, the company provides contact details for their senior communications and investor relations teams. Marisol Peron, the Senior Vice President of Global Communications & Corporate Affairs, and Andrew Carlsen, Vice President of Investor Relations, are available to answer inquiries and provide more detailed information about the company’s events and research.

Frequently Asked Questions

What is the focus of Genmab's 2024 R&D Update?

The focus will be on the latest developments in their innovative antibody therapeutics aimed at improving patient lives.

How can the public access the 2024 R&D Update?

The event will be held virtually and can be accessed via a live webcast that will also be archived for later viewing.

What is Genmab's long-term vision?

Genmab aims to transform the treatment landscape for cancer patients by 2030 with innovative therapies.

Who are key contacts for inquiries about Genmab?

Marisol Peron and Andrew Carlsen are the primary contacts for inquiries related to communications and investor relations, respectively.

What innovative therapies does Genmab focus on?

Genmab focuses on antibody-based therapies, including bispecific T-cell engagers and immune checkpoint modulators.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hamamatsu & AIxMed to Automate Cytology Workflows

Updated Category News Views 2

Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...

Continue Reading
Allison Ng Earns Prestigious NAPABA 'Best Under 40' Award

Updated Category News Views 1

Allison Ng's Achievement: Beyond the Legal Grind Without warning, the legal world has another star rising up through its ranks, and this time it's Allison Ng catching the spotlight. She’s tucked away in Greenberg Traurig’s Atlanta office, plugging away in pharmaceutical and medical device litigation. But every now and then, these legal eagles get a chance to spread...

Continue Reading
Decaf Coffee Market Grows to $5.2B by 2031 Amidst Tech Advances

Updated Category News Views 3

The java crowd is waking up to a new trend that's more than just a flash in the mug. We're looking at a market shift where the decaffeinated coffee scene is steaming ahead, geared up for a whopping $5.2 billion valuation by 2031, growing at a tidy 7% CAGR. Yeah, you read that right. So, what's brewing that's making this market percolate? Riding the Wave of...

Continue Reading
Innovation Drives New Asia-Pacific Opportunities

Updated Category News Views 0

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 6

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
LV Petroleum Expands Footprint with Key Acquisitions

Updated Category News Views 2

LV Petroleum's Bold Moves in July Ever seen a company expand across four states in a blink? LV Petroleum's been hustling like a player with a fresh hand of aces. They shut July down with restaurant openings and a fancy new travel center under their belt in states as spread out as Arizona, Texas, Nevada, and Ohio. Now that's a wide net they're casting, all in the name of...

Continue Reading
Daqo's Power Play: Transforming MEA's Energy Future

Updated Category News Views 3

Emerging Energy Challenges in the MEA Region Out here in the Middle East and Africa, the energy landscape isn't a lazy river. It's more like white-water rapids, with oil and gas on one bank and the surge of renewables on the other. At the 2026 Middle East Energy showcase, Daqo put everyone on notice with a portfolio that aims to ride those waves—no life vests needed....

Continue Reading
Eyepic 2-in-1 Camera Innovates at IFA 2026

Updated Category News Views 1

Call me a sucker for new tech but what Hohem just unveiled might flip content creation on its head. Welcome the Eyepic—a 2-in-1 pocket gimbal camera stirring things up at IFA 2026 in Berlin. Now, maybe your eyeballs are glazing over with all the camera announcements flooding the market. I get it. Yet, this gadget isn’t just another add-on; it's a sneaky move by Hohem...

Continue Reading
TECNO POVA 8 Pro 5G: Blending Speed with Style

Updated Category News Views 0

TECNO's Newest Launch: A Marriage of Luxurious Design and Performance This ain't just any phone—they've hitched a race car to your pocket. The TECNO POVA 8 Pro 5G Tonino Lamborghini Limited Edition makes a splash, promising to redefine what folks expect from a luxury-tier device, thanks to its endorsed partnership with the iconic Italian brand. But what's all this mean...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 4

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Current Landscape of GE Aerospace's Stock

Updated Category News Views 155

Current Trends in GE Aerospace's Short Interest GE Aerospace's short interest has seen a notable increase of 20.83% since the last reporting period. Currently, there are approximately 15.47 million shares sold short, representing about 1.45% of the total shares available for trading. This statistic suggests that if traders wanted to cover their short positions, it would...

Continue Reading
Univest Securities Closes $4 Million Offering for Jiuzi Holdings

Updated Category News Views 80

Univest Securities Successfully Concludes $4 Million Offering New York, December 15, 2025 — Univest Securities, LLC, a full-service investment bank based in New York, has announced the successful closing of a $4.0 million registered direct offering for its client, Jiuzi Holdings, Inc. (NASDAQ: JZXN). This strategic move is part of Jiuzi's commitment to advancing...

Continue Reading
RIFM's Journey to Revolutionize Fragrance Safety in 2025

Updated Category News Views 82

Setting the Stage for Fragrance Safety Innovations Award-winning research and novel non-animal testing methods highlight the significant strides made by the Research Institute for Fragrance Materials (RIFM) as it approaches the close of 2025. The organization has not only achieved major scientific milestones but has also fostered essential global collaborations, ensuring...

Continue Reading
Kashiv BioSciences Welcomes Dr. Sandeep Athalye as CEO

Updated Category News Views 196

Kashiv BioSciences Welcomes New Leadership Kashiv BioSciences, a prominent global player in the biopharmaceutical sector, recently made a significant strategic move by appointing Dr. Sandeep Nilkanth Athalye as their Global Chief Executive Officer. This decision is poised to bring a wealth of experience and insight to the company's mission of expanding its footprint in...

Continue Reading
CIFTIS Closing Highlights: Economic Ties and Innovations

Updated Category News Views 157

CIFTIS 2025 Concludes with Success The China International Fair for Trade in Services (CIFTIS) has successfully wrapped up its 2025 edition, showcasing the increasing importance of global connectivity in the service sector. The event, held at Shougang Park, saw more than 900 agreements signed across various industries like construction, finance, and technology, reflecting...

Continue Reading